refractory, metastatic squamous cell Non-small cell lung cancer (DBCOND0023505)

Identifiers

Synonyms

Refractory, metastatic Squamous Cell Non-small Cell Lung Cancer

Associated Data

Indicated Drugs and Targets

Drug	Description	Targets
Afatinib	An antineoplastic agent used for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) with non-resistant EGFR mutations or resistance to platinum-based chemotherapy.	Epidermal growth factor receptortarget Receptor tyrosine-protein kinase erbB-2target Receptor tyrosine-protein kinase erbB-4target ATP-dependent translocase ABCB1transporter Broad substrate specificity ATP-binding cassette transporter ABCG2transporter

Clinical Trials

Not Available